SlideShare a Scribd company logo
ACLS Update and Review
Dwight Owen
Stephanie Tang
Leticia Varella
Case
 62 yo man with met CRPC with diffuse bone






metastases s/p multiple radiation treatments with
refractory pain
Admitted with back pain for r/o spinal cord
compression
Could not tolerate MRI  CT instead without
obvious compression
Given steroids with PPI, DVT ppx
Home methadone continued during admission for
pain control, lexapro for depression, albuterol prn
for SOB (former smoker, ? Mild COPD)
Morning Sign Out
 Overnight, patient again failed to tolerate MRI

despite pre-medication with ativan and
methadone PCA
 Was agitated and aggressive, but afebrile with
other VSS, haldol x 1 given in MRI suite
Morning Rounds
 When you round on the patient in the morning, he

is unresponsive.
Vitals
 HR 96
 BP 90/60
 RR 6
 S02 88%
 Afebrile

 BG: 60
 Pinpoint pupils, no wheezing, moving ext x 4
 Naloxone 0.4 mg x1 given without improvement
Lab from yesterday
 CBC: Hgb 8.9 (baseline)
 BMP: 140/4.2
 Phos 2.5
 Mg 1.1

106/33

29/1.4 < 71
 Biphasic unsynchronized shock (ie defibrillation)

delivered at 200J
 Next step?
 ROSC obtained during next rhythm check

 Still not following commands
BLS:
Because you don’t always have a code cart
BLS
 No more “look, listen, and feel.”

 Continued emphasis has been placed on high-

quality CPR
 chest compressions of adequate rate and depth
 allowing complete chest recoil after each

compression
 minimizing interruptions in compressions
 avoiding excessive ventilation
BLS
 There has been a change in the recommended

sequence for the lone rescuer to initiate chest
compressions before giving rescue breaths (C-A-B
rather than A-B-C). The lone rescuer should begin
CPR with 30 compressions rather than 2
ventilations to reduce delay to first compression.
 Compression rate should be at least 100/min
(rather than “approximately” 100/min).
 Compression depth for adults has been changed
from the range of 1 to 2 inches to at least 2 inches
(5 cm).
AED
AED
 Shock First vs CPR First
 1-Shock Protocol vs 3-Shock Sequence (no

stacking)
 Defibrillation Waveforms and Energy Levels
(Biphasic > Monophasic)
 Synchronized Cardioversion
 Afib: Biphasic 120-200J
 Aflutter Biphasic 100 J
 If first attempt fails, increase dose incrementally
Synchronized Cardioversion
 Unstable SVT
 Unstable atrial fibrillation
 Unstable atrial flutter
 Unstable monomorphic (regular) VT

 Synchronization avoids shock delivery during the

relative refractory period of the cardiac cycle
when a shock could produce VF
Synchronized vs Unsynchronized
 If there is any doubt whether monomorphic or

polymorphic VT is present in the unstable
patient, do not delay shock delivery to perform
detailed rhythm analysis: provide high-energy
unsynchronized shocks (ie, defibrillation doses).
Treatment?
With a pulse

Adult stable monomorphic VT responds well to
monophasic or biphasic waveform cardioversion (synchronized)
shocks at initial energies of 100 J. If there is no response to the
first shock, it may be reasonable to increase the dose in a stepwise
fashion.
Treatment?
Without a pulse

Pulseless arrest algorithm
Treatment?
SBP 150

SBP 70

Unstable polymorphic ventricular tachycardia is treated with
unsynchronized shocks (defibrillation). Defibrillation is used
because synchronization is not possible.
The wave of the future
With initiation of CPR, cardiac output is the major determinant of
CO2 delivery to the lungs

100% sensitivity and 100% specificity in identifying correct
endotracheal tube placement.
40 mmHg

15 mmHg
High Quality CPR
 Maintain 30:2 ratio until advanced airway

 Minimize interruptions in CPR
 De-emphasis on Devices, Drugs, and Distractions
 Allow complete chest recoil after each

compression
 Rate of at least 100 compressions/min
Medications
 Atropine is no longer part of pulseless arrest

algorithm
 Central line ideal, however should not delay time
to CPR or meds
 IO if two failed attempts at IV
 ETT?
What medications can be absorbed
through the trachea?
 Lidocaine
 Epinephrine
 Atropine
 Naloxone
 Vasopressin
Post Cardiac-Arrest Care
 Hypothermia protocol
 Taper Fi02 to keep Sa02 > 94%
 Identify and treat ACS and other reversible

causes
 Anticipate, treat, and prevent multiple organ
dysfunction. This includes avoiding excessive
ventilation and hyperoxia.
 Transport/transfer to an appropriate hospital or
critical care unit with a comprehensive post–
cardiac arrest treatment system of care
Medications not generally
recommended during cardiac arrest
 Atropine

 Sodium Bicarbonate
 Calcium
 Fibrinolysis ?
Mega-code
 A 40 year old man arrives at the ER accompanied by his

family. He is complaining of palpitations after working
outside for several hours. The assessment is as follows:
 SKIN: pale, warm and dry

CVS: Strong peripheral pulses and a BP of 125/80
CNS: Fully intact
RESP: RR is 22, no resp. distress, lungs CTA
 An EKG is obtained
What is the next appropriate intervention?
A – Adenosine 6 mg IVP through closest line to the heart
followed by 20 ml NS push
B – Attempt vagal maneuvers
C – Perform synchronized cardioversion
D – Give epinephrine 1 mg IVP
What is the next appropriate intervention?
A – Adenosine 6 mg IVP through closest line to the heart
followed by 20 ml NS push
B – Attempt vagal maneuvers
C – Perform synchronized cardioversion
D – Give epinephrine 1 mg IVP
Lim SH et al. Comparison of treatment of supraventricular tachycardia by Valsalva
maneuver and carotid sinus massage. Ann Emerg Med 1998 Jan 31 30 35
You have performed vagal maneuvers and there is no
change in the patient’s heart rate and rhythm. What is your
next step?

 A - Give adenosine 6mg rapid IV push. If no

conversion, give 12mg rapid IV push
 B - Give adenosine 12mg rapid IV push. If no

conversion, give another 12mg rapid IV push
 C - Give Amiodarone 150mg over 10 minutes.

May repeat as needed
 D - Continue to attempt vagal manuvers until the

patient converts to a regular sinus rhythm
You have performed vagal maneuvers and there is no
change in the patients heart rate and rhythm. What is your
next step?

 A - Give adenosine 6mg rapid IV push. If no

conversion, give 12mg rapid IV push
 B - Give adenosine 12mg rapid IV push. If no

conversion, give another 12mg rapid IV push
 C - Give Amiodarone 150mg over 10 minutes.

May repeat as needed
 D - Continue to attempt vagal manuvers until the

patient converts to a regular sinus rhythm
You give 6mg Adenosine rapid IV push with no effect. 12mg
Adenosine rapid IV push is then given. The patient develops
severe ongoing chest pain and his vital signs are: HR
220, BP (not obtainable), and weak pulse. Your next step
should be.

 A – Immediate defibrillation
 B – Give 2nd dose of adenosine rapid IVP
 C – Perform immediate synchronized

cardioversion
 D – Perform precordial thump
You give 6mg Adenosine rapid IV push with no effect. 12mg
Adenosine rapid IV push is then given. The patient develops
severe ongoing chest pain and his vital signs are: HR
220, BP (not obtainable), and weak pulse. Your next step
should be.

 A – Immediate defibrillation
 B – Give 2nd dose of adenosine rapid IVP
 C – Perform immediate synchronized

cardioversion
 D – Perform precordial thump
Stable or Unstable SVT?
 Shortness of breath
 Palpitation feeling in chest
 Ongoing chest pain
 Dizziness
 Rapid breathing

 Loss of consciousness
 Numbness of body parts
Stable or Unstable SVT?
 Shortness of breath
 Palpitation feeling in chest
 Ongoing chest pain
 Dizziness
 Rapid breathing

 Loss of consciousness
 Numbness of body parts

Unstable patients with SVT and a pulse are always
treated with cardioversion
After synchronized cardioversion is unsuccessful, the pt.
continues to deteriorate. The patient is now unconscious. No
pulse is palpable. Below is what you see on the monitor:

What is your first intervention:
A – Deliver 2 minutes of CPR and then re-assess rhythm
B – Give epinephrine 1 mg IV push and repeat every 3-5 minutes
C – Give one unsynchronized shock (120-200 J)
D – Place an advanced airway
After synchronized cardioversion is unsuccessful, the pt.
continues to deteriorate. The patient is now unconscious. No
pulse is palpable. Below is what you see on the monitor:

What is your first intervention:
A – Deliver 2 minutes of CPR and then re-assess rhythm
B – Give epinephrine 1 mg IV push and repeat every 3-5 minutes
C – Give one unsynchronized shock (120-200 J)
D – Place an advanced airway
The patient does not respond to the defibrillation
with 120 J. He remains unconscious in ventricular
tachycardia. What is your next intervention?
 A – Deliver up to two additional shocks of 200 J
 B – Give 1 mg epinephrine IV push and repeat

q3-5 min
 C – Give

2 minutes of CPR

 D – Check the rhythm and the pulse
The patient does not respond to the defibrillation
with 120 J. He remains unconscious in ventricular
tachycardia. What is your next intervention?
 A – Deliver up to two additional shocks of 200 J
 B – Give 1 mg epinephrine IV push and repeat

q3-5 min
 C – Give

2 minutes of CPR

 D – Check the rhythm and the pulse
After completing 2 minutes of CPR, your rhythm check
indicates a second shock. You shock a second time with 160
J, and the patient's rhythm does not change. You resume
CPR. While completing the cycle of CPR what else should be
done?

 A – Epinephrine 1 mg IVP q3-5 min
 B – Vasopressin 40 mg IVP to replace first or

second dose of epinephrine
 C – Epinephrine 0.5 mg q3-5 min

 D – Both A and B
After completing 2 minutes of CPR, your rhythm check
indicates a second shock. You shock a second time with 160
J, and the patient's rhythm does not change. You resume
CPR. While completing the cycle of CPR what else should be
done?

 A – Epinephrine 1 mg IVP q3-5 min
 B – Vasopressin 40 mg IVP to replace first or

second dose of epinephrine
 C – Epinephrine 0.5 mg q3-5 min

 D – Both A and B
You have given the epinephrine or vasopressin and
completed the 5 cycles of CPR. A rhythm check reveals no
change. You attempt at third defibrillation. What will be your
defibrillator setting? (assume biphasic)

 A – 160 J
 B – 200 J
 C – 300 J
 D – 360 J
You have given the epinephrine or vasopressin and
completed the 5 cycles of CPR. A rhythm check reveals no
change. You attempt at third defibrillation. What will be your
defibrillator setting? (assume biphasic)

 A – 160 J
 B – 200 J
 C – 300 J
 D – 360 J
The third shock does not change the rhythm and you restart
CPR. You have shocked, you have given vasopressors
(epinephrine and/or vasopressin), you have continued with
effective CPR. What medication should be considered at this
point?

 A – Atropine
 B – Adenosine
 C – Amiodarone
 D – Amiloride
The third shock does not change the rhythm and you restart
CPR. You have shocked, you have given vasopressors
(epinephrine and/or vasopressin), you have continued with
effective CPR. What medication should be considered at this
point?

 A – Atropine
 B – Adenosine
 C – Amiodarone
 D – Amiloride
What is the correct dosing for amiodarone in the
Pulseless Arrest Algorithm?
 A – 150 mg IV once, if not effective may give one

additional dose of 300 mg IV
 B – 200 mg IV once
 C – 300 mg IV once, may be repeated with 150

mg IV one additional time
 D – Infusion of 300 mg IVPB in one hour
What is the correct dosing for amiodarone in the
Pulseless Arrest Algorithm?
 A – 150 mg IV once, if not effective may give one

additional dose of 300 mg IV
 B – 200 mg IV once
 C – 300 mg IV once, may be repeated with 150

mg IV one additional time
 D – Infusion of 300 mg IVPB in one hour
Amiodarone
 Ca Channels
 Na Channels
 K Channels
 Alpha-adrenergic
 Beta-Adrenergic
 Refractory VF/Pulseless VT
In addition to amiodarone, what other antiarrhythmic can you
consider as part of the pulseless arrest algorithm?

 A – Labetalol
 B – Lidocaine

 C – Digoxin
 D - Flecainide
In addition to amiodarone, what other anti-arrythmic can
you consider as part of the pulseless arrest algorithm?
 A – Labetalol
 B – Lidocaine

 C – Digoxin
 D - Flecainide
Great Job! You saved the patient He has been
stabilized and intubated, but does not respond to
verbal commands. He is transported to the hospital's
ICU. Since the patient is not responsive what would be
the most important intervention in the post-cardiac
arrest phase?
 A – Monitor waveform capnography
 B – Obtain ABG
 C – Induce therapeutic hypothermia

 D – Monitor oxygen saturation
Great Job! You saved the patient He has been
stabilized and intubated, but does not respond to
verbal commands. He is transported to the hospital's
ICU. Since the patient is not responsive what would be
the most important intervention in the post-cardiac
arrest phase?
 A – Monitor waveform capnography
 B – Obtain ABG
 C – Induce therapeutic hypothermia

 D – Monitor oxygen saturation
Possible Exclusion Criteria
 Coma from other cause besides cardiac

(toxins, CNS)
 Known bleeding diathesis / ongoing bleeding +/-

recent surgery
 Sepsis
 Ongoing shock with SBP < 90

More Related Content

What's hot

Defibrillation and cardioversion
Defibrillation and cardioversionDefibrillation and cardioversion
Defibrillation and cardioversion
Dr.Venugopalan Poovathum Parambil
 
Acls (2)
Acls (2)Acls (2)
Acls (2)
Sayma7
 
ACLS UPDATES.pptx
ACLS UPDATES.pptxACLS UPDATES.pptx
ACLS UPDATES.pptx
RahimiRusli1
 
ACLS
ACLSACLS
ACLS (Advanced cardiac life support)
ACLS (Advanced cardiac life support)ACLS (Advanced cardiac life support)
ACLS (Advanced cardiac life support)
Abhay Rajpoot
 
Adult medical emergencies
Adult medical emergenciesAdult medical emergencies
Adult medical emergencies
Swarnalingam Thangavel
 
ACLS & BLS
ACLS & BLSACLS & BLS
ACLS & BLS
Abhay Rajpoot
 
als cardiac arrest and rosc
 als cardiac arrest and rosc als cardiac arrest and rosc
als cardiac arrest and rosc
MEEQAT HOSPITAL
 
Advanced cardiac life support(acls)
Advanced cardiac life support(acls)Advanced cardiac life support(acls)
Advanced cardiac life support(acls)
omar143
 
Basic Life Support (BLS)
Basic Life Support (BLS)Basic Life Support (BLS)
Basic Life Support (BLS)
Zain Khan
 
Cpr guideline in pregnacy
Cpr guideline in pregnacyCpr guideline in pregnacy
Cpr guideline in pregnacy
Akorli Jonathan Oluwadamilare
 
Basic & advanced life support updates 2020
Basic & advanced life support updates 2020Basic & advanced life support updates 2020
Basic & advanced life support updates 2020
Dr Abd Elaal Elbahnasy
 
Basic life support
Basic life supportBasic life support
Basic life support
Kerolus Shehata
 
Procedural Sedation
Procedural SedationProcedural Sedation
Procedural Sedation
SCGH ED CME
 
Post resuscitation care
Post resuscitation carePost resuscitation care
Post resuscitation careKane Guthrie
 
Mitral stenosis and Anesthesia
Mitral stenosis and AnesthesiaMitral stenosis and Anesthesia
Mitral stenosis and Anesthesia
Dr.S.N.Bhagirath ..
 
Defibrillation & cardioversion by DJ
Defibrillation & cardioversion by DJDefibrillation & cardioversion by DJ
Defibrillation & cardioversion by DJ
Dharmendra Joshi
 
Code blue
Code blueCode blue
Code bluewcmc
 
Basic CPR .pptx
Basic CPR .pptxBasic CPR .pptx

What's hot (20)

Defibrillation and cardioversion
Defibrillation and cardioversionDefibrillation and cardioversion
Defibrillation and cardioversion
 
Acls (2)
Acls (2)Acls (2)
Acls (2)
 
ACLS UPDATES.pptx
ACLS UPDATES.pptxACLS UPDATES.pptx
ACLS UPDATES.pptx
 
ACLS
ACLSACLS
ACLS
 
ACLS (Advanced cardiac life support)
ACLS (Advanced cardiac life support)ACLS (Advanced cardiac life support)
ACLS (Advanced cardiac life support)
 
Adult medical emergencies
Adult medical emergenciesAdult medical emergencies
Adult medical emergencies
 
ACLS & BLS
ACLS & BLSACLS & BLS
ACLS & BLS
 
als cardiac arrest and rosc
 als cardiac arrest and rosc als cardiac arrest and rosc
als cardiac arrest and rosc
 
Advanced cardiac life support(acls)
Advanced cardiac life support(acls)Advanced cardiac life support(acls)
Advanced cardiac life support(acls)
 
Basic Life Support (BLS)
Basic Life Support (BLS)Basic Life Support (BLS)
Basic Life Support (BLS)
 
Cpr guideline in pregnacy
Cpr guideline in pregnacyCpr guideline in pregnacy
Cpr guideline in pregnacy
 
Basic & advanced life support updates 2020
Basic & advanced life support updates 2020Basic & advanced life support updates 2020
Basic & advanced life support updates 2020
 
Basic life support
Basic life supportBasic life support
Basic life support
 
Procedural Sedation
Procedural SedationProcedural Sedation
Procedural Sedation
 
Post resuscitation care
Post resuscitation carePost resuscitation care
Post resuscitation care
 
Basic life support
Basic life supportBasic life support
Basic life support
 
Mitral stenosis and Anesthesia
Mitral stenosis and AnesthesiaMitral stenosis and Anesthesia
Mitral stenosis and Anesthesia
 
Defibrillation & cardioversion by DJ
Defibrillation & cardioversion by DJDefibrillation & cardioversion by DJ
Defibrillation & cardioversion by DJ
 
Code blue
Code blueCode blue
Code blue
 
Basic CPR .pptx
Basic CPR .pptxBasic CPR .pptx
Basic CPR .pptx
 

Viewers also liked

ACLS update
ACLS updateACLS update
ACLS update
SCGH ED CME
 
Defibrillatorppt 131028115457-phpapp01
Defibrillatorppt 131028115457-phpapp01Defibrillatorppt 131028115457-phpapp01
Defibrillatorppt 131028115457-phpapp01
tarek klai
 
Defibrillation
DefibrillationDefibrillation
Defibrillation
Joyce Wilson
 
Defibrillator
Defibrillator Defibrillator
Defibrillator
sumanth reddy
 
Defibrillation presentation
Defibrillation presentationDefibrillation presentation
Defibrillation presentation
Shanebrad
 
Geriatric trauma
Geriatric traumaGeriatric trauma
Geriatric trauma
SCGH ED CME
 
Defibrillation, cardioversion and pacing
Defibrillation, cardioversion and pacingDefibrillation, cardioversion and pacing
Defibrillation, cardioversion and pacing
snich
 
defibrillation and cardioversion
 defibrillation and cardioversion defibrillation and cardioversion
defibrillation and cardioversionMohammed Awwad
 

Viewers also liked (11)

Defibrillation
DefibrillationDefibrillation
Defibrillation
 
Defibrilllation
DefibrilllationDefibrilllation
Defibrilllation
 
ACLS update
ACLS updateACLS update
ACLS update
 
Defibrillatorppt 131028115457-phpapp01
Defibrillatorppt 131028115457-phpapp01Defibrillatorppt 131028115457-phpapp01
Defibrillatorppt 131028115457-phpapp01
 
Defibrillation
DefibrillationDefibrillation
Defibrillation
 
Defibrillator
Defibrillator Defibrillator
Defibrillator
 
Defibrillation presentation
Defibrillation presentationDefibrillation presentation
Defibrillation presentation
 
Geriatric trauma
Geriatric traumaGeriatric trauma
Geriatric trauma
 
Defibrillation, cardioversion and pacing
Defibrillation, cardioversion and pacingDefibrillation, cardioversion and pacing
Defibrillation, cardioversion and pacing
 
Defibrillators
DefibrillatorsDefibrillators
Defibrillators
 
defibrillation and cardioversion
 defibrillation and cardioversion defibrillation and cardioversion
defibrillation and cardioversion
 

Similar to ACLS - update and review

ECG FOR acls
ECG FOR acls ECG FOR acls
ECG FOR acls
Munir Ahmad Mughal
 
Advanced Cardiac Life Support
Advanced Cardiac Life SupportAdvanced Cardiac Life Support
Advanced Cardiac Life Supportmeducationdotnet
 
Anesthesiology (Ezekiel 2005)
Anesthesiology (Ezekiel 2005)Anesthesiology (Ezekiel 2005)
Anesthesiology (Ezekiel 2005)guest068a73
 
Introduction to CPR and it's importance.pptx
Introduction to CPR and it's importance.pptxIntroduction to CPR and it's importance.pptx
Introduction to CPR and it's importance.pptx
NahidIslam38
 
CPR introduction and mechanisms to do.pptx
CPR introduction and mechanisms to do.pptxCPR introduction and mechanisms to do.pptx
CPR introduction and mechanisms to do.pptx
NahidIslam38
 
First Aid BLS & ACLS slidesEnglish.pptx
First Aid  BLS & ACLS slidesEnglish.pptxFirst Aid  BLS & ACLS slidesEnglish.pptx
First Aid BLS & ACLS slidesEnglish.pptx
amruthapk8
 
Acls update
Acls  updateAcls  update
Acls update
Mashiul Alam
 
Approach to Chest pain
Approach to Chest pain Approach to Chest pain
Approach to Chest pain
ahm732
 
Acls mega code pdf
Acls mega code pdfAcls mega code pdf
Acls mega code pdf
ceipem
 
acls-advancedcardiaclifesupport-180829150251.pdf
acls-advancedcardiaclifesupport-180829150251.pdfacls-advancedcardiaclifesupport-180829150251.pdf
acls-advancedcardiaclifesupport-180829150251.pdf
sagarpoudel45
 
Acls advanced cardiac life support
Acls   advanced cardiac life supportAcls   advanced cardiac life support
Acls advanced cardiac life support
Vipin Mahadevan
 
CPR In Pediatric (Pediatric Advanced Life Support)
CPR In Pediatric (Pediatric Advanced Life Support) CPR In Pediatric (Pediatric Advanced Life Support)
CPR In Pediatric (Pediatric Advanced Life Support)
Zana Hossam
 
Drihabsuliman
DrihabsulimanDrihabsuliman
Drihabsuliman
hospital
 
Approach to tachyarrhythmia
Approach to tachyarrhythmiaApproach to tachyarrhythmia
Approach to tachyarrhythmia
KTD Priyadarshani
 
Cardiac arrest(rev 4 2011)
Cardiac arrest(rev 4 2011)Cardiac arrest(rev 4 2011)
Cardiac arrest(rev 4 2011)
Mohan Tiru
 
CPR GUIDELINES-2005
CPR GUIDELINES-2005CPR GUIDELINES-2005
CPR GUIDELINES-2005
Unnikrishnan Prathapadas
 
acls-advancedcardiaclifesupport-180829150251 (2) (2).ppt
acls-advancedcardiaclifesupport-180829150251 (2) (2).pptacls-advancedcardiaclifesupport-180829150251 (2) (2).ppt
acls-advancedcardiaclifesupport-180829150251 (2) (2).ppt
SonuPaul8
 
Random ECGs 2
Random ECGs 2Random ECGs 2
Random ECGs 2
chricres
 

Similar to ACLS - update and review (20)

Cpcr
CpcrCpcr
Cpcr
 
ECG FOR acls
ECG FOR acls ECG FOR acls
ECG FOR acls
 
Advanced Cardiac Life Support
Advanced Cardiac Life SupportAdvanced Cardiac Life Support
Advanced Cardiac Life Support
 
Anesthesiology (Ezekiel 2005)
Anesthesiology (Ezekiel 2005)Anesthesiology (Ezekiel 2005)
Anesthesiology (Ezekiel 2005)
 
Introduction to CPR and it's importance.pptx
Introduction to CPR and it's importance.pptxIntroduction to CPR and it's importance.pptx
Introduction to CPR and it's importance.pptx
 
CPR introduction and mechanisms to do.pptx
CPR introduction and mechanisms to do.pptxCPR introduction and mechanisms to do.pptx
CPR introduction and mechanisms to do.pptx
 
First Aid BLS & ACLS slidesEnglish.pptx
First Aid  BLS & ACLS slidesEnglish.pptxFirst Aid  BLS & ACLS slidesEnglish.pptx
First Aid BLS & ACLS slidesEnglish.pptx
 
Updates in ACLS 2005
Updates in ACLS 2005Updates in ACLS 2005
Updates in ACLS 2005
 
Acls update
Acls  updateAcls  update
Acls update
 
Approach to Chest pain
Approach to Chest pain Approach to Chest pain
Approach to Chest pain
 
Acls mega code pdf
Acls mega code pdfAcls mega code pdf
Acls mega code pdf
 
acls-advancedcardiaclifesupport-180829150251.pdf
acls-advancedcardiaclifesupport-180829150251.pdfacls-advancedcardiaclifesupport-180829150251.pdf
acls-advancedcardiaclifesupport-180829150251.pdf
 
Acls advanced cardiac life support
Acls   advanced cardiac life supportAcls   advanced cardiac life support
Acls advanced cardiac life support
 
CPR In Pediatric (Pediatric Advanced Life Support)
CPR In Pediatric (Pediatric Advanced Life Support) CPR In Pediatric (Pediatric Advanced Life Support)
CPR In Pediatric (Pediatric Advanced Life Support)
 
Drihabsuliman
DrihabsulimanDrihabsuliman
Drihabsuliman
 
Approach to tachyarrhythmia
Approach to tachyarrhythmiaApproach to tachyarrhythmia
Approach to tachyarrhythmia
 
Cardiac arrest(rev 4 2011)
Cardiac arrest(rev 4 2011)Cardiac arrest(rev 4 2011)
Cardiac arrest(rev 4 2011)
 
CPR GUIDELINES-2005
CPR GUIDELINES-2005CPR GUIDELINES-2005
CPR GUIDELINES-2005
 
acls-advancedcardiaclifesupport-180829150251 (2) (2).ppt
acls-advancedcardiaclifesupport-180829150251 (2) (2).pptacls-advancedcardiaclifesupport-180829150251 (2) (2).ppt
acls-advancedcardiaclifesupport-180829150251 (2) (2).ppt
 
Random ECGs 2
Random ECGs 2Random ECGs 2
Random ECGs 2
 

More from derosaMSKCC

Heme talk 10 29-15- dr james
Heme talk 10 29-15- dr  jamesHeme talk 10 29-15- dr  james
Heme talk 10 29-15- dr james
derosaMSKCC
 
Vte path and rx
Vte path and rx Vte path and rx
Vte path and rx
derosaMSKCC
 
Coag testing for hema fellows mskcc 10 15 2015 dr peerschke
Coag testing for hema fellows mskcc 10 15 2015   dr  peerschkeCoag testing for hema fellows mskcc 10 15 2015   dr  peerschke
Coag testing for hema fellows mskcc 10 15 2015 dr peerschke
derosaMSKCC
 
Hemophilia fellow talk2015 dr parameswaran
Hemophilia fellow talk2015    dr  parameswaranHemophilia fellow talk2015    dr  parameswaran
Hemophilia fellow talk2015 dr parameswaran
derosaMSKCC
 
Drug induced hemolytic anemia cc 10 8-15 - dr mehta-shah
Drug induced hemolytic anemia cc 10 8-15 - dr  mehta-shahDrug induced hemolytic anemia cc 10 8-15 - dr  mehta-shah
Drug induced hemolytic anemia cc 10 8-15 - dr mehta-shah
derosaMSKCC
 
Heme conf 10 08-2015 - dr cho
Heme conf 10 08-2015 - dr  choHeme conf 10 08-2015 - dr  cho
Heme conf 10 08-2015 - dr choderosaMSKCC
 
Work life fit and wellness
Work life fit and wellnessWork life fit and wellness
Work life fit and wellness
derosaMSKCC
 
Gi bleed
Gi bleedGi bleed
Gi bleed
derosaMSKCC
 
Anemia 101
Anemia 101Anemia 101
Anemia 101
derosaMSKCC
 
Hepatology 101
Hepatology 101Hepatology 101
Hepatology 101
derosaMSKCC
 
Approach to abdominal pain
Approach to abdominal painApproach to abdominal pain
Approach to abdominal pain
derosaMSKCC
 
Immunotherapy 101
Immunotherapy 101Immunotherapy 101
Immunotherapy 101
derosaMSKCC
 
Immunotherapy 101
Immunotherapy 101Immunotherapy 101
Immunotherapy 101derosaMSKCC
 
heme_case_092415
heme_case_092415heme_case_092415
heme_case_092415
derosaMSKCC
 
update on blood product alternatives
update on blood product alternativesupdate on blood product alternatives
update on blood product alternatives
derosaMSKCC
 
Vwd
Vwd Vwd
Chest pain
Chest painChest pain
Chest pain
derosaMSKCC
 
Nf and tls
Nf and tlsNf and tls
Nf and tls
derosaMSKCC
 
Empiric antibiotic management for major infections
Empiric antibiotic management for major infectionsEmpiric antibiotic management for major infections
Empiric antibiotic management for major infections
derosaMSKCC
 
Pneumonia ty boot camp
Pneumonia ty boot campPneumonia ty boot camp
Pneumonia ty boot camp
derosaMSKCC
 

More from derosaMSKCC (20)

Heme talk 10 29-15- dr james
Heme talk 10 29-15- dr  jamesHeme talk 10 29-15- dr  james
Heme talk 10 29-15- dr james
 
Vte path and rx
Vte path and rx Vte path and rx
Vte path and rx
 
Coag testing for hema fellows mskcc 10 15 2015 dr peerschke
Coag testing for hema fellows mskcc 10 15 2015   dr  peerschkeCoag testing for hema fellows mskcc 10 15 2015   dr  peerschke
Coag testing for hema fellows mskcc 10 15 2015 dr peerschke
 
Hemophilia fellow talk2015 dr parameswaran
Hemophilia fellow talk2015    dr  parameswaranHemophilia fellow talk2015    dr  parameswaran
Hemophilia fellow talk2015 dr parameswaran
 
Drug induced hemolytic anemia cc 10 8-15 - dr mehta-shah
Drug induced hemolytic anemia cc 10 8-15 - dr  mehta-shahDrug induced hemolytic anemia cc 10 8-15 - dr  mehta-shah
Drug induced hemolytic anemia cc 10 8-15 - dr mehta-shah
 
Heme conf 10 08-2015 - dr cho
Heme conf 10 08-2015 - dr  choHeme conf 10 08-2015 - dr  cho
Heme conf 10 08-2015 - dr cho
 
Work life fit and wellness
Work life fit and wellnessWork life fit and wellness
Work life fit and wellness
 
Gi bleed
Gi bleedGi bleed
Gi bleed
 
Anemia 101
Anemia 101Anemia 101
Anemia 101
 
Hepatology 101
Hepatology 101Hepatology 101
Hepatology 101
 
Approach to abdominal pain
Approach to abdominal painApproach to abdominal pain
Approach to abdominal pain
 
Immunotherapy 101
Immunotherapy 101Immunotherapy 101
Immunotherapy 101
 
Immunotherapy 101
Immunotherapy 101Immunotherapy 101
Immunotherapy 101
 
heme_case_092415
heme_case_092415heme_case_092415
heme_case_092415
 
update on blood product alternatives
update on blood product alternativesupdate on blood product alternatives
update on blood product alternatives
 
Vwd
Vwd Vwd
Vwd
 
Chest pain
Chest painChest pain
Chest pain
 
Nf and tls
Nf and tlsNf and tls
Nf and tls
 
Empiric antibiotic management for major infections
Empiric antibiotic management for major infectionsEmpiric antibiotic management for major infections
Empiric antibiotic management for major infections
 
Pneumonia ty boot camp
Pneumonia ty boot campPneumonia ty boot camp
Pneumonia ty boot camp
 

Recently uploaded

Surgical Site Infections, pathophysiology, and prevention.pptx
Surgical Site Infections, pathophysiology, and prevention.pptxSurgical Site Infections, pathophysiology, and prevention.pptx
Surgical Site Infections, pathophysiology, and prevention.pptx
jval Landero
 
BRACHYTHERAPY OVERVIEW AND APPLICATORS
BRACHYTHERAPY OVERVIEW  AND  APPLICATORSBRACHYTHERAPY OVERVIEW  AND  APPLICATORS
BRACHYTHERAPY OVERVIEW AND APPLICATORS
Krishan Murari
 
Phone Us ❤85270-49040❤ #ℂall #gIRLS In Surat By Surat @ℂall @Girls Hotel With...
Phone Us ❤85270-49040❤ #ℂall #gIRLS In Surat By Surat @ℂall @Girls Hotel With...Phone Us ❤85270-49040❤ #ℂall #gIRLS In Surat By Surat @ℂall @Girls Hotel With...
Phone Us ❤85270-49040❤ #ℂall #gIRLS In Surat By Surat @ℂall @Girls Hotel With...
Savita Shen $i11
 
Alcohol_Dr. Jeenal Mistry MD Pharmacology.pdf
Alcohol_Dr. Jeenal Mistry MD Pharmacology.pdfAlcohol_Dr. Jeenal Mistry MD Pharmacology.pdf
Alcohol_Dr. Jeenal Mistry MD Pharmacology.pdf
Dr Jeenal Mistry
 
basicmodesofventilation2022-220313203758.pdf
basicmodesofventilation2022-220313203758.pdfbasicmodesofventilation2022-220313203758.pdf
basicmodesofventilation2022-220313203758.pdf
aljamhori teaching hospital
 
Evaluation of antidepressant activity of clitoris ternatea in animals
Evaluation of antidepressant activity of clitoris ternatea in animalsEvaluation of antidepressant activity of clitoris ternatea in animals
Evaluation of antidepressant activity of clitoris ternatea in animals
Shweta
 
Ozempic: Preoperative Management of Patients on GLP-1 Receptor Agonists
Ozempic: Preoperative Management of Patients on GLP-1 Receptor Agonists  Ozempic: Preoperative Management of Patients on GLP-1 Receptor Agonists
Ozempic: Preoperative Management of Patients on GLP-1 Receptor Agonists
Saeid Safari
 
Pulmonary Thromboembolism - etilogy, types, medical- Surgical and nursing man...
Pulmonary Thromboembolism - etilogy, types, medical- Surgical and nursing man...Pulmonary Thromboembolism - etilogy, types, medical- Surgical and nursing man...
Pulmonary Thromboembolism - etilogy, types, medical- Surgical and nursing man...
VarunMahajani
 
Flu Vaccine Alert in Bangalore Karnataka
Flu Vaccine Alert in Bangalore KarnatakaFlu Vaccine Alert in Bangalore Karnataka
Flu Vaccine Alert in Bangalore Karnataka
addon Scans
 
ARTHROLOGY PPT NCISM SYLLABUS AYURVEDA STUDENTS
ARTHROLOGY PPT NCISM SYLLABUS AYURVEDA STUDENTSARTHROLOGY PPT NCISM SYLLABUS AYURVEDA STUDENTS
ARTHROLOGY PPT NCISM SYLLABUS AYURVEDA STUDENTS
Dr. Vinay Pareek
 
THOA 2.ppt Human Organ Transplantation Act
THOA 2.ppt Human Organ Transplantation ActTHOA 2.ppt Human Organ Transplantation Act
THOA 2.ppt Human Organ Transplantation Act
DrSathishMS1
 
Antiulcer drugs Advance Pharmacology .pptx
Antiulcer drugs Advance Pharmacology .pptxAntiulcer drugs Advance Pharmacology .pptx
Antiulcer drugs Advance Pharmacology .pptx
Rohit chaurpagar
 
BENIGN PROSTATIC HYPERPLASIA.BPH. BPHpdf
BENIGN PROSTATIC HYPERPLASIA.BPH. BPHpdfBENIGN PROSTATIC HYPERPLASIA.BPH. BPHpdf
BENIGN PROSTATIC HYPERPLASIA.BPH. BPHpdf
DR SETH JOTHAM
 
Physiology of Special Chemical Sensation of Taste
Physiology of Special Chemical Sensation of TastePhysiology of Special Chemical Sensation of Taste
Physiology of Special Chemical Sensation of Taste
MedicoseAcademics
 
Report Back from SGO 2024: What’s the Latest in Cervical Cancer?
Report Back from SGO 2024: What’s the Latest in Cervical Cancer?Report Back from SGO 2024: What’s the Latest in Cervical Cancer?
Report Back from SGO 2024: What’s the Latest in Cervical Cancer?
bkling
 
Prix Galien International 2024 Forum Program
Prix Galien International 2024 Forum ProgramPrix Galien International 2024 Forum Program
Prix Galien International 2024 Forum Program
Levi Shapiro
 
POST OPERATIVE OLIGURIA and its management
POST OPERATIVE OLIGURIA and its managementPOST OPERATIVE OLIGURIA and its management
POST OPERATIVE OLIGURIA and its management
touseefaziz1
 
The POPPY STUDY (Preconception to post-partum cardiovascular function in prim...
The POPPY STUDY (Preconception to post-partum cardiovascular function in prim...The POPPY STUDY (Preconception to post-partum cardiovascular function in prim...
The POPPY STUDY (Preconception to post-partum cardiovascular function in prim...
Catherine Liao
 
Maxilla, Mandible & Hyoid Bone & Clinical Correlations by Dr. RIG.pptx
Maxilla, Mandible & Hyoid Bone & Clinical Correlations by Dr. RIG.pptxMaxilla, Mandible & Hyoid Bone & Clinical Correlations by Dr. RIG.pptx
Maxilla, Mandible & Hyoid Bone & Clinical Correlations by Dr. RIG.pptx
Dr. Rabia Inam Gandapore
 
New Directions in Targeted Therapeutic Approaches for Older Adults With Mantl...
New Directions in Targeted Therapeutic Approaches for Older Adults With Mantl...New Directions in Targeted Therapeutic Approaches for Older Adults With Mantl...
New Directions in Targeted Therapeutic Approaches for Older Adults With Mantl...
i3 Health
 

Recently uploaded (20)

Surgical Site Infections, pathophysiology, and prevention.pptx
Surgical Site Infections, pathophysiology, and prevention.pptxSurgical Site Infections, pathophysiology, and prevention.pptx
Surgical Site Infections, pathophysiology, and prevention.pptx
 
BRACHYTHERAPY OVERVIEW AND APPLICATORS
BRACHYTHERAPY OVERVIEW  AND  APPLICATORSBRACHYTHERAPY OVERVIEW  AND  APPLICATORS
BRACHYTHERAPY OVERVIEW AND APPLICATORS
 
Phone Us ❤85270-49040❤ #ℂall #gIRLS In Surat By Surat @ℂall @Girls Hotel With...
Phone Us ❤85270-49040❤ #ℂall #gIRLS In Surat By Surat @ℂall @Girls Hotel With...Phone Us ❤85270-49040❤ #ℂall #gIRLS In Surat By Surat @ℂall @Girls Hotel With...
Phone Us ❤85270-49040❤ #ℂall #gIRLS In Surat By Surat @ℂall @Girls Hotel With...
 
Alcohol_Dr. Jeenal Mistry MD Pharmacology.pdf
Alcohol_Dr. Jeenal Mistry MD Pharmacology.pdfAlcohol_Dr. Jeenal Mistry MD Pharmacology.pdf
Alcohol_Dr. Jeenal Mistry MD Pharmacology.pdf
 
basicmodesofventilation2022-220313203758.pdf
basicmodesofventilation2022-220313203758.pdfbasicmodesofventilation2022-220313203758.pdf
basicmodesofventilation2022-220313203758.pdf
 
Evaluation of antidepressant activity of clitoris ternatea in animals
Evaluation of antidepressant activity of clitoris ternatea in animalsEvaluation of antidepressant activity of clitoris ternatea in animals
Evaluation of antidepressant activity of clitoris ternatea in animals
 
Ozempic: Preoperative Management of Patients on GLP-1 Receptor Agonists
Ozempic: Preoperative Management of Patients on GLP-1 Receptor Agonists  Ozempic: Preoperative Management of Patients on GLP-1 Receptor Agonists
Ozempic: Preoperative Management of Patients on GLP-1 Receptor Agonists
 
Pulmonary Thromboembolism - etilogy, types, medical- Surgical and nursing man...
Pulmonary Thromboembolism - etilogy, types, medical- Surgical and nursing man...Pulmonary Thromboembolism - etilogy, types, medical- Surgical and nursing man...
Pulmonary Thromboembolism - etilogy, types, medical- Surgical and nursing man...
 
Flu Vaccine Alert in Bangalore Karnataka
Flu Vaccine Alert in Bangalore KarnatakaFlu Vaccine Alert in Bangalore Karnataka
Flu Vaccine Alert in Bangalore Karnataka
 
ARTHROLOGY PPT NCISM SYLLABUS AYURVEDA STUDENTS
ARTHROLOGY PPT NCISM SYLLABUS AYURVEDA STUDENTSARTHROLOGY PPT NCISM SYLLABUS AYURVEDA STUDENTS
ARTHROLOGY PPT NCISM SYLLABUS AYURVEDA STUDENTS
 
THOA 2.ppt Human Organ Transplantation Act
THOA 2.ppt Human Organ Transplantation ActTHOA 2.ppt Human Organ Transplantation Act
THOA 2.ppt Human Organ Transplantation Act
 
Antiulcer drugs Advance Pharmacology .pptx
Antiulcer drugs Advance Pharmacology .pptxAntiulcer drugs Advance Pharmacology .pptx
Antiulcer drugs Advance Pharmacology .pptx
 
BENIGN PROSTATIC HYPERPLASIA.BPH. BPHpdf
BENIGN PROSTATIC HYPERPLASIA.BPH. BPHpdfBENIGN PROSTATIC HYPERPLASIA.BPH. BPHpdf
BENIGN PROSTATIC HYPERPLASIA.BPH. BPHpdf
 
Physiology of Special Chemical Sensation of Taste
Physiology of Special Chemical Sensation of TastePhysiology of Special Chemical Sensation of Taste
Physiology of Special Chemical Sensation of Taste
 
Report Back from SGO 2024: What’s the Latest in Cervical Cancer?
Report Back from SGO 2024: What’s the Latest in Cervical Cancer?Report Back from SGO 2024: What’s the Latest in Cervical Cancer?
Report Back from SGO 2024: What’s the Latest in Cervical Cancer?
 
Prix Galien International 2024 Forum Program
Prix Galien International 2024 Forum ProgramPrix Galien International 2024 Forum Program
Prix Galien International 2024 Forum Program
 
POST OPERATIVE OLIGURIA and its management
POST OPERATIVE OLIGURIA and its managementPOST OPERATIVE OLIGURIA and its management
POST OPERATIVE OLIGURIA and its management
 
The POPPY STUDY (Preconception to post-partum cardiovascular function in prim...
The POPPY STUDY (Preconception to post-partum cardiovascular function in prim...The POPPY STUDY (Preconception to post-partum cardiovascular function in prim...
The POPPY STUDY (Preconception to post-partum cardiovascular function in prim...
 
Maxilla, Mandible & Hyoid Bone & Clinical Correlations by Dr. RIG.pptx
Maxilla, Mandible & Hyoid Bone & Clinical Correlations by Dr. RIG.pptxMaxilla, Mandible & Hyoid Bone & Clinical Correlations by Dr. RIG.pptx
Maxilla, Mandible & Hyoid Bone & Clinical Correlations by Dr. RIG.pptx
 
New Directions in Targeted Therapeutic Approaches for Older Adults With Mantl...
New Directions in Targeted Therapeutic Approaches for Older Adults With Mantl...New Directions in Targeted Therapeutic Approaches for Older Adults With Mantl...
New Directions in Targeted Therapeutic Approaches for Older Adults With Mantl...
 

ACLS - update and review

  • 1. ACLS Update and Review Dwight Owen Stephanie Tang Leticia Varella
  • 2. Case  62 yo man with met CRPC with diffuse bone     metastases s/p multiple radiation treatments with refractory pain Admitted with back pain for r/o spinal cord compression Could not tolerate MRI  CT instead without obvious compression Given steroids with PPI, DVT ppx Home methadone continued during admission for pain control, lexapro for depression, albuterol prn for SOB (former smoker, ? Mild COPD)
  • 3. Morning Sign Out  Overnight, patient again failed to tolerate MRI despite pre-medication with ativan and methadone PCA  Was agitated and aggressive, but afebrile with other VSS, haldol x 1 given in MRI suite
  • 4. Morning Rounds  When you round on the patient in the morning, he is unresponsive.
  • 5. Vitals  HR 96  BP 90/60  RR 6  S02 88%  Afebrile  BG: 60  Pinpoint pupils, no wheezing, moving ext x 4  Naloxone 0.4 mg x1 given without improvement
  • 6. Lab from yesterday  CBC: Hgb 8.9 (baseline)  BMP: 140/4.2  Phos 2.5  Mg 1.1 106/33 29/1.4 < 71
  • 7.
  • 8.  Biphasic unsynchronized shock (ie defibrillation) delivered at 200J  Next step?  ROSC obtained during next rhythm check  Still not following commands
  • 9. BLS: Because you don’t always have a code cart
  • 10. BLS  No more “look, listen, and feel.”  Continued emphasis has been placed on high- quality CPR  chest compressions of adequate rate and depth  allowing complete chest recoil after each compression  minimizing interruptions in compressions  avoiding excessive ventilation
  • 11. BLS  There has been a change in the recommended sequence for the lone rescuer to initiate chest compressions before giving rescue breaths (C-A-B rather than A-B-C). The lone rescuer should begin CPR with 30 compressions rather than 2 ventilations to reduce delay to first compression.  Compression rate should be at least 100/min (rather than “approximately” 100/min).  Compression depth for adults has been changed from the range of 1 to 2 inches to at least 2 inches (5 cm).
  • 12. AED
  • 13. AED  Shock First vs CPR First  1-Shock Protocol vs 3-Shock Sequence (no stacking)  Defibrillation Waveforms and Energy Levels (Biphasic > Monophasic)  Synchronized Cardioversion  Afib: Biphasic 120-200J  Aflutter Biphasic 100 J  If first attempt fails, increase dose incrementally
  • 14. Synchronized Cardioversion  Unstable SVT  Unstable atrial fibrillation  Unstable atrial flutter  Unstable monomorphic (regular) VT  Synchronization avoids shock delivery during the relative refractory period of the cardiac cycle when a shock could produce VF
  • 15. Synchronized vs Unsynchronized  If there is any doubt whether monomorphic or polymorphic VT is present in the unstable patient, do not delay shock delivery to perform detailed rhythm analysis: provide high-energy unsynchronized shocks (ie, defibrillation doses).
  • 16. Treatment? With a pulse Adult stable monomorphic VT responds well to monophasic or biphasic waveform cardioversion (synchronized) shocks at initial energies of 100 J. If there is no response to the first shock, it may be reasonable to increase the dose in a stepwise fashion.
  • 18. Treatment? SBP 150 SBP 70 Unstable polymorphic ventricular tachycardia is treated with unsynchronized shocks (defibrillation). Defibrillation is used because synchronization is not possible.
  • 19. The wave of the future
  • 20. With initiation of CPR, cardiac output is the major determinant of CO2 delivery to the lungs 100% sensitivity and 100% specificity in identifying correct endotracheal tube placement.
  • 22.
  • 23.
  • 24.
  • 25.
  • 26. High Quality CPR  Maintain 30:2 ratio until advanced airway  Minimize interruptions in CPR  De-emphasis on Devices, Drugs, and Distractions  Allow complete chest recoil after each compression  Rate of at least 100 compressions/min
  • 27. Medications  Atropine is no longer part of pulseless arrest algorithm  Central line ideal, however should not delay time to CPR or meds  IO if two failed attempts at IV  ETT?
  • 28. What medications can be absorbed through the trachea?  Lidocaine  Epinephrine  Atropine  Naloxone  Vasopressin
  • 29. Post Cardiac-Arrest Care  Hypothermia protocol  Taper Fi02 to keep Sa02 > 94%  Identify and treat ACS and other reversible causes  Anticipate, treat, and prevent multiple organ dysfunction. This includes avoiding excessive ventilation and hyperoxia.  Transport/transfer to an appropriate hospital or critical care unit with a comprehensive post– cardiac arrest treatment system of care
  • 30.
  • 31. Medications not generally recommended during cardiac arrest  Atropine  Sodium Bicarbonate  Calcium  Fibrinolysis ?
  • 32. Mega-code  A 40 year old man arrives at the ER accompanied by his family. He is complaining of palpitations after working outside for several hours. The assessment is as follows:  SKIN: pale, warm and dry CVS: Strong peripheral pulses and a BP of 125/80 CNS: Fully intact RESP: RR is 22, no resp. distress, lungs CTA  An EKG is obtained
  • 33.
  • 34. What is the next appropriate intervention? A – Adenosine 6 mg IVP through closest line to the heart followed by 20 ml NS push B – Attempt vagal maneuvers C – Perform synchronized cardioversion D – Give epinephrine 1 mg IVP
  • 35. What is the next appropriate intervention? A – Adenosine 6 mg IVP through closest line to the heart followed by 20 ml NS push B – Attempt vagal maneuvers C – Perform synchronized cardioversion D – Give epinephrine 1 mg IVP Lim SH et al. Comparison of treatment of supraventricular tachycardia by Valsalva maneuver and carotid sinus massage. Ann Emerg Med 1998 Jan 31 30 35
  • 36. You have performed vagal maneuvers and there is no change in the patient’s heart rate and rhythm. What is your next step?  A - Give adenosine 6mg rapid IV push. If no conversion, give 12mg rapid IV push  B - Give adenosine 12mg rapid IV push. If no conversion, give another 12mg rapid IV push  C - Give Amiodarone 150mg over 10 minutes. May repeat as needed  D - Continue to attempt vagal manuvers until the patient converts to a regular sinus rhythm
  • 37. You have performed vagal maneuvers and there is no change in the patients heart rate and rhythm. What is your next step?  A - Give adenosine 6mg rapid IV push. If no conversion, give 12mg rapid IV push  B - Give adenosine 12mg rapid IV push. If no conversion, give another 12mg rapid IV push  C - Give Amiodarone 150mg over 10 minutes. May repeat as needed  D - Continue to attempt vagal manuvers until the patient converts to a regular sinus rhythm
  • 38. You give 6mg Adenosine rapid IV push with no effect. 12mg Adenosine rapid IV push is then given. The patient develops severe ongoing chest pain and his vital signs are: HR 220, BP (not obtainable), and weak pulse. Your next step should be.  A – Immediate defibrillation  B – Give 2nd dose of adenosine rapid IVP  C – Perform immediate synchronized cardioversion  D – Perform precordial thump
  • 39. You give 6mg Adenosine rapid IV push with no effect. 12mg Adenosine rapid IV push is then given. The patient develops severe ongoing chest pain and his vital signs are: HR 220, BP (not obtainable), and weak pulse. Your next step should be.  A – Immediate defibrillation  B – Give 2nd dose of adenosine rapid IVP  C – Perform immediate synchronized cardioversion  D – Perform precordial thump
  • 40. Stable or Unstable SVT?  Shortness of breath  Palpitation feeling in chest  Ongoing chest pain  Dizziness  Rapid breathing  Loss of consciousness  Numbness of body parts
  • 41. Stable or Unstable SVT?  Shortness of breath  Palpitation feeling in chest  Ongoing chest pain  Dizziness  Rapid breathing  Loss of consciousness  Numbness of body parts Unstable patients with SVT and a pulse are always treated with cardioversion
  • 42. After synchronized cardioversion is unsuccessful, the pt. continues to deteriorate. The patient is now unconscious. No pulse is palpable. Below is what you see on the monitor: What is your first intervention: A – Deliver 2 minutes of CPR and then re-assess rhythm B – Give epinephrine 1 mg IV push and repeat every 3-5 minutes C – Give one unsynchronized shock (120-200 J) D – Place an advanced airway
  • 43. After synchronized cardioversion is unsuccessful, the pt. continues to deteriorate. The patient is now unconscious. No pulse is palpable. Below is what you see on the monitor: What is your first intervention: A – Deliver 2 minutes of CPR and then re-assess rhythm B – Give epinephrine 1 mg IV push and repeat every 3-5 minutes C – Give one unsynchronized shock (120-200 J) D – Place an advanced airway
  • 44. The patient does not respond to the defibrillation with 120 J. He remains unconscious in ventricular tachycardia. What is your next intervention?  A – Deliver up to two additional shocks of 200 J  B – Give 1 mg epinephrine IV push and repeat q3-5 min  C – Give 2 minutes of CPR  D – Check the rhythm and the pulse
  • 45. The patient does not respond to the defibrillation with 120 J. He remains unconscious in ventricular tachycardia. What is your next intervention?  A – Deliver up to two additional shocks of 200 J  B – Give 1 mg epinephrine IV push and repeat q3-5 min  C – Give 2 minutes of CPR  D – Check the rhythm and the pulse
  • 46. After completing 2 minutes of CPR, your rhythm check indicates a second shock. You shock a second time with 160 J, and the patient's rhythm does not change. You resume CPR. While completing the cycle of CPR what else should be done?  A – Epinephrine 1 mg IVP q3-5 min  B – Vasopressin 40 mg IVP to replace first or second dose of epinephrine  C – Epinephrine 0.5 mg q3-5 min  D – Both A and B
  • 47. After completing 2 minutes of CPR, your rhythm check indicates a second shock. You shock a second time with 160 J, and the patient's rhythm does not change. You resume CPR. While completing the cycle of CPR what else should be done?  A – Epinephrine 1 mg IVP q3-5 min  B – Vasopressin 40 mg IVP to replace first or second dose of epinephrine  C – Epinephrine 0.5 mg q3-5 min  D – Both A and B
  • 48. You have given the epinephrine or vasopressin and completed the 5 cycles of CPR. A rhythm check reveals no change. You attempt at third defibrillation. What will be your defibrillator setting? (assume biphasic)  A – 160 J  B – 200 J  C – 300 J  D – 360 J
  • 49. You have given the epinephrine or vasopressin and completed the 5 cycles of CPR. A rhythm check reveals no change. You attempt at third defibrillation. What will be your defibrillator setting? (assume biphasic)  A – 160 J  B – 200 J  C – 300 J  D – 360 J
  • 50. The third shock does not change the rhythm and you restart CPR. You have shocked, you have given vasopressors (epinephrine and/or vasopressin), you have continued with effective CPR. What medication should be considered at this point?  A – Atropine  B – Adenosine  C – Amiodarone  D – Amiloride
  • 51. The third shock does not change the rhythm and you restart CPR. You have shocked, you have given vasopressors (epinephrine and/or vasopressin), you have continued with effective CPR. What medication should be considered at this point?  A – Atropine  B – Adenosine  C – Amiodarone  D – Amiloride
  • 52. What is the correct dosing for amiodarone in the Pulseless Arrest Algorithm?  A – 150 mg IV once, if not effective may give one additional dose of 300 mg IV  B – 200 mg IV once  C – 300 mg IV once, may be repeated with 150 mg IV one additional time  D – Infusion of 300 mg IVPB in one hour
  • 53. What is the correct dosing for amiodarone in the Pulseless Arrest Algorithm?  A – 150 mg IV once, if not effective may give one additional dose of 300 mg IV  B – 200 mg IV once  C – 300 mg IV once, may be repeated with 150 mg IV one additional time  D – Infusion of 300 mg IVPB in one hour
  • 54. Amiodarone  Ca Channels  Na Channels  K Channels  Alpha-adrenergic  Beta-Adrenergic  Refractory VF/Pulseless VT
  • 55. In addition to amiodarone, what other antiarrhythmic can you consider as part of the pulseless arrest algorithm?  A – Labetalol  B – Lidocaine  C – Digoxin  D - Flecainide
  • 56. In addition to amiodarone, what other anti-arrythmic can you consider as part of the pulseless arrest algorithm?  A – Labetalol  B – Lidocaine  C – Digoxin  D - Flecainide
  • 57. Great Job! You saved the patient He has been stabilized and intubated, but does not respond to verbal commands. He is transported to the hospital's ICU. Since the patient is not responsive what would be the most important intervention in the post-cardiac arrest phase?  A – Monitor waveform capnography  B – Obtain ABG  C – Induce therapeutic hypothermia  D – Monitor oxygen saturation
  • 58. Great Job! You saved the patient He has been stabilized and intubated, but does not respond to verbal commands. He is transported to the hospital's ICU. Since the patient is not responsive what would be the most important intervention in the post-cardiac arrest phase?  A – Monitor waveform capnography  B – Obtain ABG  C – Induce therapeutic hypothermia  D – Monitor oxygen saturation
  • 59. Possible Exclusion Criteria  Coma from other cause besides cardiac (toxins, CNS)  Known bleeding diathesis / ongoing bleeding +/- recent surgery  Sepsis  Ongoing shock with SBP < 90

Editor's Notes

  1. Patients who do not respond to a total dose of 5 to 10 mg should undergo evaluation for alternative causes of encephalopathy.DDx: opiod intox, NMS, serotonin syndrome less likely (Afebrile), hypoglycemia, COPD exac?
  2. Although no published human or animal evidencedemonstrates that starting CPR with 30 compressionsrather than 2 ventilations leads to improved outcome, chestcompressions provide the blood flow, and studies of out-ofhospitaladult cardiac arrest showed that survival was higherwhen bystanders provided chest compressions rather than nochest compressions.
  3. In most studies, delivery of more compressions during resuscitation is associated with better survival, and delivery of fewer compressions is associated with lower survival.
  4. The total number of compressions delivered during resuscitationis an important determinant of survival from cardiac arrest.The number of compressions delivered is affected by thecompression rate and by the compression fraction (the portionof total CPR time during which compressions are performed)
  5. When any rescuer witnesses an out-of-hospital arrest and an AED is immediately available on-site, the rescuer should start CPR with chest compressions and use the AED as soon as possible. Healthcare providers who treat cardiac arrest in hospitals and other facilities with on-site AEDs or defibrillators should provide immediate CPR and should use the AED/defibrillator as soon as it is available. These recommendations are designed to support early CPR and early defibrillation, particularly when an AED or defibrillator is available within moments of the onset of sudden cardiac arrest. When an out-of-hospital cardiac arrest is not witnessed by EMS personnel, EMS may initiate CPR while checking the rhythm with the AED or on the electrocardiogram (ECG) and preparing for defibrillation. In such instances, 1.to 3 minutes of CPR may be considered before attempted defibrillation. Whenever 2 or more rescuers are present, CPRshould be provided while the defibrillator is retrieved.With in-hospital sudden cardiac arrest, there is insufficient evidence to support or refute CPR before defibrillation.However, in monitored patients, the time from VF to shock delivery should be under 3 minutes, and CPR should beperformed while the defibrillator is readied.When VF is present for more than a few minutes, the myocardium is depleted of oxygen and energy. A brief periodof chest compressions can deliver oxygen and energy to the heart, increasing the likelihood that a shock will both eliminate VF (defibrillation) and be followed by ROSC. Before the publication of the 2005 AHA Guidelines for CPR and ECC, 2 studies suggested the potential benefit of CPR first rather than shock first. In both studies, although 1. to 3 minutes of CPR before shock delivery did not improve overall survival from VF, the CPR-first strategy did improve survival among victims with VF if the EMS call-to-arrival interval was 4 to 5 minutes or longer. However, 2 subsequent randomized controlled trials found that CPR before attempted defibrillation by EMS personnel was not associated with a significant difference in survival to discharge. One retrospective study did find an improved neurologic status at 30 days and at 1 year when immediate CPR was compared with immediate defibrillation in patients with out-of-hospital VF.
  6. Adult stable monomorphic VT responds well tomonophasic or biphasic waveform cardioversion (synchronized)shocks at initial energies of 100 J. If there is no response to thefirst shock, it may be reasonable to increase the dose in a stepwisefashion.Synchronized cardioversion must not be used for treatmentof VF because the device is unlikely to sense a QRS wave,and thus, a shock may not be delivered.When VF is present for more than afew minutes, the myocardium is depleted of oxygen andmetabolic substrates. A brief period of chest compressionscan deliver oxygen and energy substrates and “unload” thevolume-overloaded right ventricle, increasing the likelihoodthat a perfusing rhythm will return after shockdelivery.
  7. Adult stable monomorphic VT responds well tomonophasic or biphasic waveform cardioversion (synchronized)shocks at initial energies of 100 J. If there is no response to thefirst shock, it may be reasonable to increase the dose in a stepwisefashion.Synchronized cardioversion must not be used for treatmentof VF because the device is unlikely to sense a QRS wave,and thus, a shock may not be delivered.When VF is present for more than afew minutes, the myocardium is depleted of oxygen andmetabolic substrates. A brief period of chest compressionscan deliver oxygen and energy substrates and “unload” thevolume-overloaded right ventricle, increasing the likelihoodthat a perfusing rhythm will return after shockdelivery.
  8. Unstable polymorphic ventricular tachycardia is treated with unsynchronized shocks (defibrillation). Defibrillation is used because synchronization is not possible.Synchronized cardioversion must not be used for treatmentof VF because the device is unlikely to sense a QRS wave,and thus, a shock may not be delivered.
  9. Studies of waveform capnography to verify endotracheal tube position in victims of cardiac arrest have shown 100% sensitivity and 100% specificity in identifying correct endotracheal tube placement.During untreated cardiac arrest CO2 continues to be produced in the body, but there is no CO2 delivery to thelungs. Under these conditions PETCO2 will approach zero with continued ventilation. With initiation of CPR, cardiacoutput is the major determinant of CO2 delivery to the lungs. If ventilation is relatively constant, PETCO2 correlates well with cardiac output during CPR.
  10. Quantitative waveform capnography is recommended for confirmation and monitoring of endotracheal tube placementand CPR quality.
  11. There is no definitiveclinical evidence that early intubation or drug therapy improvesneurologically intact survival to hospital discharge.
  12. If IV or IO access cannot be established, epinephrine,vasopressin, and lidocaine may be administered by theendotracheal route during cardiac arrest (Class IIb, LOE B).The optimal endotracheal dose of most drugs is unknown, buttypically the dose given by the endotracheal route is 2 to 21⁄2times the recommended IV dose.Providers should dilute the recommended dose in 5 to 10 mLof sterile water or normal saline and inject the drug directlyinto the endotracheal tube.256 Studies with epinephrine263 andlidocaine251 showed that dilution with sterile water instead of0.9% saline may achieve better drug absorption.
  13. Since 2005, two nonrandomized studies with concurrentcontrols and other studies using historic controls haveindicated the possible benefit of therapeutic hypothermiaafter in-hospital cardiac arrest and out-of-hospital cardiacarrest with PEA/asystole as the presenting rhythm.As noted above, an oxygen saturation of 100% maycorrespond to a Pao2 anywhere between approximately 80 and500 mm Hg.
  14. Bicarbonate may compromise CPP by reducing systemic vascular resistance.313 It can create extracellular alkalosisthat will shift the oxyhemoglobin saturation curve and inhibit oxygen release. It can produce hypernatremia andtherefore hyperosmolarity. It produces excess CO2, which freely diffuses into myocardial and cerebral cells and mayparadoxically contribute to intracellular acidosis.314 It can exacerbate central venous acidosis and may inactivate simultaneously administered catecholamines.In some special resuscitation situations, such as preexisting metabolic acidosis, hyperkalemia, or tricyclic antidepressant overdose, bicarbonate can be beneficial
  15. Lim SH et al. Comparison of treatment of supraventricular tachycardia by Valsalva maneuver and carotid sinus massage. Ann Emerg Med 1998 Jan 31 30 35 Conversion rate of up to 28% with nonpharmacologic therapy
  16. Lim SH et al. Comparison of treatment of supraventricular tachycardia by Valsalva maneuver and carotid sinus massage. Ann Emerg Med 1998 Jan 31 30 35 Conversion rate of up to 28% with nonpharmacologic therapy
  17. Adenosine is recommended in the initial diagnosisand treatment of stable, undifferentiated regular, monomorphicwide-complex tachycardia (this is also consistent in ACLS andPALS recommendations). It is important to note that adenosineshould not be used for irregular wide-complex tachycardiasbecause it may cause degeneration of the rhythm to VF.
  18. The heart fills during diastole, and diastole is normally 2/3 the cardiac cycle. A rapid heart rate will significantly reduce the time which the ventricles have to fill. The reduced filling time results in a smaller amount of blood ejected from the heart during systole. The end result is a drop in cardiac output &amp; hypotension.Unstable patients with SVT and a pulse are always treated with cardioversion
  19. The 4 most common types of SVT are A-V Nodal Reentry Tachycardia, A-VReentry Tachycardia, atrial tachycardia and atrial flutter. These rhythmsare regular in nature and have a rate &gt; 150. To distinguish the differencebetween the re-entry tachycardias and the other types really requires a 12lead ECG. The diagnostic criteria to determine that it is a reentranttachycardia is actually quite complex.
  20. pulseless ventricular tachycardia.